BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21934071)

  • 1. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
    Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
    J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
    Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
    Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells.
    Oura J; Tamura Y; Kamiguchi K; Kutomi G; Sahara H; Torigoe T; Himi T; Sato N
    Int Immunol; 2011 Apr; 23(4):223-37. PubMed ID: 21421737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation.
    Hirosue S; Kourtis IC; van der Vlies AJ; Hubbell JA; Swartz MA
    Vaccine; 2010 Nov; 28(50):7897-906. PubMed ID: 20934457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of endogenous heat shock protein 90 of dendritic cells in antigen cross-presentation.
    Ichiyanagi T; Imai T; Kajiwara C; Mizukami S; Nakai A; Nakayama T; Udono H
    J Immunol; 2010 Sep; 185(5):2693-700. PubMed ID: 20668218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II.
    Ilchmann A; Burgdorf S; Scheurer S; Waibler Z; Nagai R; Wellner A; Yamamoto Y; Yamamoto H; Henle T; Kurts C; Kalinke U; Vieths S; Toda M
    J Allergy Clin Immunol; 2010 Jan; 125(1):175-83.e1-11. PubMed ID: 19864011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T cell proliferation during the induction of inhalation tolerance.
    Fear VS; Burchell JT; Lai SP; Wikstrom ME; Blank F; von Garnier C; Turner DJ; Sly PD; Holt PG; Strickland DS; Stumbles PA
    J Immunol; 2011 Nov; 187(9):4561-70. PubMed ID: 21930961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.
    Rodríguez T; Pérez O; Ménager N; Ugrinovic S; Bracho G; Mastroeni P
    Vaccine; 2005 Jan; 23(10):1312-21. PubMed ID: 15652674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza A virus elevates active cathepsin B in primary murine DC.
    Burster T; Giffon T; Dahl ME; Björck P; Bogyo M; Weber E; Mahmood K; Lewis DB; Mellins ED
    Int Immunol; 2007 May; 19(5):645-55. PubMed ID: 17446210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
    Ebihara S; Endo S; Ito K; Ito Y; Akiyama K; Obinata M; Takai T
    J Biochem; 2004 Sep; 136(3):321-8. PubMed ID: 15598888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model.
    Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK
    Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
    Jähn PS; Zänker KS; Schmitz J; Dzionek A
    Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].
    de Brito C; Tomkowiak M; Ghittoni R; Caux C; Leverrier Y; Marvel J
    J Immunol; 2011 Feb; 186(3):1503-11. PubMed ID: 21187449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.